FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328100101> ?p ?o ?g. }

• W4328100101 endingPage "769" @default.
• W4328100101 startingPage "759" @default.
• W4328100101 abstract "Current rates of permanent pacemaker implantation (PPMI) after transcatheter aortic valve implantation (TAVI) range between 3.4% and 25.9%. PPMI is associated with a worse prognosis. A lower valve implantation depth is associated with an increased risk of conduction disturbances. Theoretically, cusp-overlap projection (COP) has the potential to enable higher valve deployment. To compare the 30-day PPMI incidence post-TAVI using self-expanding valves according to the fluoroscopic guidance technique. This retrospective single-center study assessed consecutive patients undergoing TAVI with CoreValve™ valves between April 2019 and November 2021, grouped according to the fluoroscopic guidance technique (COP vs. coplanar implantation technique [CIT]). A total of 122 patients were included, predominantly women (52.5%), with a mean age of 81.6±5.5 years. COP was used in 49.2% of the sample. The CIT group had a significantly higher prevalence of previous beta-blocker use (p<0.01), lower baseline left ventricular ejection fraction (p=0.04) and a higher EuroSCORE II (p=0.02). The 30-day PPMI rate was 27.9% (n=34), with no significant difference between the COP and CIT groups (26.7% vs. 29.0%, p=0.77). Complete atrioventricular block was the main cause (38.5%). Likewise, mean fluoroscopy time (p=0.14) and contrast volume (p=0.35) used were similar between the two groups. Radiation dose was lower in the COP group (p=0.02). There was no significant difference between post-TAVI grades III and IV aortic valve regurgitation (p=0.27) and there were no cases of periprocedural acute coronary occlusion. This study shows that the COP technique, although safe and not associated with increased complexity, did not significantly reduce the 30-day PPMI rate compared to the traditional CIT view. Atualmente, a prevalência de implantação de pacemaker permanente (PPMI) após colocação de válvulas aórticas percutâneas (VAP) varia entre 3,4-25,9%, estando tal necessidade associada a um pior prognóstico. A implantação baixa da prótese valvular determina um maior risco de desenvolvimento de distúrbios de condução. A técnica angiográfica de implantação da VAP baseada na sobreposição de cúspides (COP) possibilita teoricamente a libertação mais alta da prótese. Comparar a prevalência de PPMI aos 30 dias pós-VAP com válvulas autoexpansíveis, de acordo com a técnica fluoroscópica usada aquando da implantação. Estudo retrospetivo e unicêntrico baseado na análise de doentes consecutivamente submetidos a VAP com CoreValveTM entre abril de 2019 e novembro de 2021, dicotomizados de acordo com a técnica de fluoroscópica usada aquando da implantação protésica (COP versus técnica coplanar padrão - CIT). Foram incluídos 122 doentes, predominantemente mulheres (52,5%), com uma idade média de 81,6±5,5 anos. A técnica COP foi utilizada em 49,2% da amostra. O grupo em que foi aplicada a CIT apresentou uma prevalência significativamente maior de uso prévio de betabloqueador (p<0,01), menor fração de ejeção ventricular esquerda basal (p=0,04) e maior EuroSCORE II (p=0,02). A prevalência de PPMI 30 dias pós-VAP foi de 27,9% (n=34), sem diferença significativa entre os grupos COP e CIT (26,7% versus 29,0%, p=0,77). O bloqueio auriculoventricular completo foi a causa subjacente mais comum (38,5%). De igual modo, não se identificaram diferenças estatisticamente significativas relativas ao tempo médio de fluoroscopia (p=0,14) e volume de contraste (p=0,35) usados entre os dois grupos. A dose de radiação usada foi significativamente mais baixa com a aplicação da técnica de COP (p=0,02). Não se verificou diferença quanto à percentagem de doentes com regurgitação aórtica graus III ou IV pós-VAP entre os dois grupos (p=0,27) e não se registaram casos de oclusão coronária aguda peri-procedimento. A técnica fluoroscópica COP, embora segura e não associada a um aumento da complexidade, não reduziu significativamente a prevalência de PPMI aos 30 dias pós-VAP quando comparada à utilização da técnica angiográfica tradicional." @default.
• W4328100101 created "2023-03-22" @default.
• W4328100101 creator A5002526303 @default.
• W4328100101 creator A5008772542 @default.
• W4328100101 creator A5035460212 @default.
• W4328100101 creator A5042952565 @default.
• W4328100101 creator A5047914979 @default.
• W4328100101 creator A5051159381 @default.
• W4328100101 creator A5068673871 @default.
• W4328100101 creator A5084520492 @default.
• W4328100101 date "2023-09-01" @default.
• W4328100101 modified "2023-10-03" @default.
• W4328100101 title "Impact of the use of cusp-overlap projection on the incidence of permanent pacemaker implantation post-transcatheter aortic valve implantation with self-expanding valves" @default.
• W4328100101 cites W14387645 @default.
• W4328100101 cites W1596023507 @default.
• W4328100101 cites W1951884286 @default.
• W4328100101 cites W1957796426 @default.
• W4328100101 cites W1978121427 @default.
• W4328100101 cites W1995904944 @default.
• W4328100101 cites W2165258820 @default.
• W4328100101 cites W2254946724 @default.
• W4328100101 cites W2324073140 @default.
• W4328100101 cites W2534062750 @default.
• W4328100101 cites W2548384528 @default.
• W4328100101 cites W2551157276 @default.
• W4328100101 cites W2555902851 @default.
• W4328100101 cites W2557004725 @default.
• W4328100101 cites W2596188051 @default.
• W4328100101 cites W2606654769 @default.
• W4328100101 cites W2790332731 @default.
• W4328100101 cites W2792858659 @default.
• W4328100101 cites W2888446624 @default.
• W4328100101 cites W2913461640 @default.
• W4328100101 cites W2921388585 @default.
• W4328100101 cites W2922215374 @default.
• W4328100101 cites W2969722774 @default.
• W4328100101 cites W2995309367 @default.
• W4328100101 cites W3048055512 @default.
• W4328100101 cites W3091655327 @default.
• W4328100101 cites W3108509862 @default.
• W4328100101 cites W3157571414 @default.
• W4328100101 cites W3180420739 @default.
• W4328100101 cites W3217576295 @default.
• W4328100101 cites W4206768721 @default.
• W4328100101 cites W4250082639 @default.
• W4328100101 doi "https://doi.org/10.1016/j.repc.2022.10.011" @default.
• W4328100101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36948457" @default.
• W4328100101 hasPublicationYear "2023" @default.
• W4328100101 type Work @default.
• W4328100101 citedByCount "0" @default.
• W4328100101 crossrefType "journal-article" @default.
• W4328100101 hasAuthorship W4328100101A5002526303 @default.
• W4328100101 hasAuthorship W4328100101A5008772542 @default.
• W4328100101 hasAuthorship W4328100101A5035460212 @default.
• W4328100101 hasAuthorship W4328100101A5042952565 @default.
• W4328100101 hasAuthorship W4328100101A5047914979 @default.
• W4328100101 hasAuthorship W4328100101A5051159381 @default.
• W4328100101 hasAuthorship W4328100101A5068673871 @default.
• W4328100101 hasAuthorship W4328100101A5084520492 @default.
• W4328100101 hasBestOaLocation W43281001011 @default.
• W4328100101 hasConcept C126322002 @default.
• W4328100101 hasConcept C141071460 @default.
• W4328100101 hasConcept C164705383 @default.
• W4328100101 hasConcept C2776805002 @default.
• W4328100101 hasConcept C2778198053 @default.
• W4328100101 hasConcept C2778557577 @default.
• W4328100101 hasConcept C2780168065 @default.
• W4328100101 hasConcept C2780714102 @default.
• W4328100101 hasConcept C2989005 @default.
• W4328100101 hasConcept C3017863430 @default.
• W4328100101 hasConcept C71924100 @default.
• W4328100101 hasConcept C78085059 @default.
• W4328100101 hasConceptScore W4328100101C126322002 @default.
• W4328100101 hasConceptScore W4328100101C141071460 @default.
• W4328100101 hasConceptScore W4328100101C164705383 @default.
• W4328100101 hasConceptScore W4328100101C2776805002 @default.
• W4328100101 hasConceptScore W4328100101C2778198053 @default.
• W4328100101 hasConceptScore W4328100101C2778557577 @default.
• W4328100101 hasConceptScore W4328100101C2780168065 @default.
• W4328100101 hasConceptScore W4328100101C2780714102 @default.
• W4328100101 hasConceptScore W4328100101C2989005 @default.
• W4328100101 hasConceptScore W4328100101C3017863430 @default.
• W4328100101 hasConceptScore W4328100101C71924100 @default.
• W4328100101 hasConceptScore W4328100101C78085059 @default.
• W4328100101 hasIssue "9" @default.
• W4328100101 hasLocation W43281001011 @default.
• W4328100101 hasLocation W43281001012 @default.
• W4328100101 hasOpenAccess W4328100101 @default.
• W4328100101 hasPrimaryLocation W43281001011 @default.
• W4328100101 hasRelatedWork W1964892974 @default.
• W4328100101 hasRelatedWork W2065977163 @default.
• W4328100101 hasRelatedWork W2072871835 @default.
• W4328100101 hasRelatedWork W2156133006 @default.
• W4328100101 hasRelatedWork W2369844522 @default.
• W4328100101 hasRelatedWork W2418183260 @default.
• W4328100101 hasRelatedWork W2469815070 @default.
• W4328100101 hasRelatedWork W2548484271 @default.
• W4328100101 hasRelatedWork W2736002100 @default.

• next